Norman Wolmark, MD
NRG Oncology · NSABP Foundation Inc · NSBP Foundation, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Norman Wolmark, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:35 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05705401 · Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast CancerNRG Oncology · active not recruiting · HER2-positive Breast Cancer · principal investigator
- Ph2NCT05178576 · A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant ChemotherapyNSABP Foundation Inc · withdrawn · Colon Cancer · principal investigator
- Ph2NCT04024800 · Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast CancerNuGenerex Immuno-Oncology · unknown · Triple-negative Breast Cancer · principal investigator
- Ph2NCT03628066 · Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph1NCT03626922 · Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer PatientsNSABP Foundation Inc · unknown · Metastatic Colorectal Cancer · principal investigator
- Ph2NCT03457896 · Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 StatusNSABP Foundation Inc · unknown · Metastatic Colorectal Cancer · principal investigator
- Ph2NCT03412643 · Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 SignalingNSABP Foundation Inc · unknown · HER2-negative Breast Cancer · principal investigator
- Ph3NCT03281954 · Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or PlaceboNSABP Foundation Inc · active not recruiting · Triple Negative Breast Cancer · principal investigator
- Ph2NCT03102047 · Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal CancerNSABP Foundation Inc · completed · Rectal Cancer · principal investigator
- Ph2NCT03007407 · Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on ChemotherapyNSABP Foundation Inc · completed · Colorectal Cancer Metastatic · principal investigator
- Ph3NCT02664077 · A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon CancerNSABP Foundation Inc · terminated · Stage III (IIIB or IIIC) Colon Cancer · principal investigator
- Ph2NCT02296801 · A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast CancerNSABP Foundation Inc · completed · Breast Cancer, Breast Carcinoma, Breast Tumors · principal investigator
- Ph1/Ph2NCT02236000 · A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph1/Ph2NCT01960023 · Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal CancerNSABP Foundation Inc · withdrawn · Colorectal Cancer · principal investigator
- Ph2NCT01889680 · Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal CancerNSABP Foundation Inc · withdrawn · Colorectal Cancer, Metastatic Colorectal Cancer · principal investigator
- N/ANCT01872975 · Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and SurgeryNSABP Foundation Inc · active not recruiting · Stage IB Breast Cancer, Stage II Breast Cancer · principal investigator
- N/ANCT01850628 · NSABP Biospecimen Discovery ProjectNSABP Foundation Inc · unknown · Breast Cancer · principal investigator
- N/ANCT01793805 · NSABP Patient Registry and Biospecimen Profiling RepositoryNSABP Foundation Inc · completed · Colorectal Cancer · principal investigator
- Ph2NCT01705691 · Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast CancerNSABP Foundation Inc · completed · Breast Cancer, HER2-negative Breast Cancer · principal investigator
- Ph3NCT01547741 · Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph1NCT01423123 · Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- N/ANCT01399359 · Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- N/ANCT01286233 · Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32NSABP Foundation Inc · unknown · Breast Cancer, Depression, Fatigue · principal investigator
- Ph3NCT01189227 · Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By SurgeryNSABP Foundation Inc · terminated · Colorectal Cancer, Metastatic Cancer · principal investigator
- Ph3NCT01011478 · Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By SurgeryNSABP Foundation Inc · terminated · Colorectal Cancer, Precancerous Condition · principal investigator
- Ph2NCT01008150 · Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- N/ANCT00914043 · Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45NSABP Foundation Inc · withdrawn · Breast Cancer, Fatigue · principal investigator
- Ph3NCT00887536 · A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph2NCT00803647 · A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the LiverNSABP Foundation Inc · completed · Metastatic Colorectal Cancer · principal investigator
- Ph3NCT00625898 · BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabNSABP Foundation Inc · terminated · Breast Cancer · principal investigator
- Ph3NCT00486668 · A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast CancerNSABP Foundation Inc · unknown · Invasive Breast Cancer · principal investigator
- Ph2NCT00464646 · Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph3NCT00427570 · Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By SurgeryNSABP Foundation Inc · completed · Colorectal Cancer · study chair
- Ph3NCT00427310 · Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing SurgeryNSABP Foundation Inc · completed · Colorectal Cancer · principal investigator
- Ph3NCT00425152 · Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon CancerNSABP Foundation Inc · completed · Colorectal Cancer · study chair
- N/ANCT00410579 · Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal CancersNSABP Foundation Inc · completed · Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults · study chair
- Ph3NCT00408408 · Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryNSABP Foundation Inc · unknown · Breast Cancer · principal investigator
- Ph3NCT00382070 · Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerNSABP Foundation Inc · unknown · Breast Cancer · principal investigator
- Ph2NCT00378313 · A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast CancerNSABP Foundation Inc · completed · Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer · principal investigator
- Ph2NCT00365417 · Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph2NCT00346099 · Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the RectumNSABP Foundation Inc · withdrawn · Rectal Cancer, Neoplasm Metastasis · principal investigator
- Ph2NCT00321828 · Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By SurgeryNSABP Foundation Inc · completed · Colorectal Cancer · principal investigator
- Ph2NCT00314353 · Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the ColonNSABP Foundation Inc · terminated · Colorectal Neoplasms · principal investigator
- Ph3NCT00268463 · Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal CancerNSABP Foundation Inc · terminated · Colorectal Cancer, Metastatic Cancer · principal investigator
- Ph2NCT00110695 · Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast CancerNSABP Foundation Inc · completed · Breast Neoplasms · principal investigator
- N/ANCT00103181 · Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph3NCT00093795 · Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- N/ANCT00089323 · Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph3NCT00087256 · Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon CancerNSABP Foundation Inc · terminated · Colorectal Cancer · principal investigator
- Ph3NCT00087178 · Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph2NCT00003352 · Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph3NCT00058474 · Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal CancerNSABP Foundation Inc · unknown · Colorectal Cancer · principal investigator
- Ph3NCT00053898 · Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation TherapyNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph3NCT00003830 · Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph3NCT00004067 · Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2NSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph3NCT00009945 · Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast CancerNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph3NCT00003782 · Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph NodesNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph3NCT00003906 · Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenNSABP Foundation Inc · completed · Breast Cancer · study chair
- Ph3NCT00016432 · Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of TamoxifenNSABP Foundation Inc · completed · Breast Cancer · principal investigator
- Ph2NCT00052169 · Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast CancerNSABP Foundation Inc · completed · Breast Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- NRG Oncology Network Group Operations CenterU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2014 to 2026Named on NCT05705401
- NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECTU10CA012027 · NCI · NSABP FOUNDATION, INC. · PI NORMAN WOLMARK · fiscal years 1985 to 2012Named on NCT01872975, NCT00425152, NCT00382070, NCT00321828, NCT00268463, NCT00093795, NCT00087178, NCT00003830
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.